113 related articles for article (PubMed ID: 2503460)
1. [Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].
Jung G; Holler E; Kolb HJ; Wilmanns W
Internist (Berl); 1989 Jun; 30(6):386-8. PubMed ID: 2503460
[No Abstract] [Full Text] [Related]
2. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
[TBL] [Abstract][Full Text] [Related]
3. Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
Benekli M; Hahn T; Williams BT; Cooper M; Roy HN; Wallace P; Stewart C; Bambach B; McCarthy PL
Bone Marrow Transplant; 2006 Sep; 38(5):365-70. PubMed ID: 16862164
[TBL] [Abstract][Full Text] [Related]
4. [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction].
Faure P; d'Agay MF; Tricot G; Gluckman E; Brocheriou C
Ann Pathol; 1986; 6(2):137-43. PubMed ID: 3015160
[TBL] [Abstract][Full Text] [Related]
5. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation.
Forés R; Díez-Martin JL; Briz M; Cabrera JR; Sanjuán I; Regidor C; Garcia-Talavera J; Fernandez MN
Bone Marrow Transplant; 1996 Mar; 17(3):439-41. PubMed ID: 8704703
[TBL] [Abstract][Full Text] [Related]
6. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
Szer J; Grigg AP; Phillips GL; Sheridan WP
Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
[TBL] [Abstract][Full Text] [Related]
7. Orthoclone OKT3 for graft failure after allogeneic bone marrow transplantation: a case report.
Yen CC; Chen PM; Chiou TJ; Hsieh RK
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Feb; 59(2):126-31. PubMed ID: 9175303
[TBL] [Abstract][Full Text] [Related]
8. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
[TBL] [Abstract][Full Text] [Related]
9. Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia.
Lehmann LE; Guinan EC; Halpern SL; Donovan MJ; Bierer BE; Parsons SK
Bone Marrow Transplant; 1997 Apr; 19(8):849-51. PubMed ID: 9134181
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature.
Matthes-Martin S; Mann G; Peters C; Lion T; Fritsch G; Haas OA; Pötschger U; Gadner H
Bone Marrow Transplant; 2000 Aug; 26(4):377-82. PubMed ID: 10982283
[TBL] [Abstract][Full Text] [Related]
11. Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.
Gleixner B; Kolb HJ; Holler E; Liesenfeld S; Riedner C; Hiller E; Seeber C; Kempeni J; Möller A; Knabe H
Bone Marrow Transplant; 1991 Aug; 8(2):93-8. PubMed ID: 1933064
[TBL] [Abstract][Full Text] [Related]
12. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
[TBL] [Abstract][Full Text] [Related]
13. [Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)].
Fukushima T; Kuriyama K; Yoshida S; Nagai K; Miyazaki Y; Moriuti Y; Tomonaga M
Rinsho Ketsueki; 1994 Feb; 35(2):171-6. PubMed ID: 8139116
[TBL] [Abstract][Full Text] [Related]
14. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
[No Abstract] [Full Text] [Related]
16. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
[TBL] [Abstract][Full Text] [Related]
17. OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.
Prentice HG
J Clin Immunol; 1982 Jul; 2(3 Suppl):148S-153S. PubMed ID: 6290527
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow transplantation from an HLA-identical old father in a patient with acute myelomonocytic leukemia].
Itoh K; Hiruma K; Wakita H; Endoh N; Igarashi T; Wong P; Asai T; Yoshida S
Rinsho Ketsueki; 1988 Nov; 29(11):2152-7. PubMed ID: 3070079
[No Abstract] [Full Text] [Related]
19. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
[No Abstract] [Full Text] [Related]
20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
